D3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adults

Clinical Endocrinology

Volumn 72, Issue 6, 2010, Pages 807-813

  Moyes, V J ^a,b   Walker, D M ^a   Owusu Antwi, S ^a   Maher, K T ^a   Metherell, L ^b   Akker, S A ^a   Monson, J P ^a   Clark, A J L ^b   Drake, W M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE; ISOPROTEIN; PHARMACOLOGICAL BIOMARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DNA EXTRACTION; DRUG DOSE TITRATION; EXON; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GAMMA KNIFE RADIOSURGERY; GENE DELETION; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; DEFICIENCY; GENETICS; HORMONE SUBSTITUTION; INDIVIDUALITY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, PHARMACOLOGICAL; EXONS; FEMALE; GENE DELETION; GENETIC HETEROGENEITY; GENOTYPE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INDIVIDUALITY; MALE; MIDDLE AGED; PROTEIN ISOFORMS; RECEPTORS, SOMATOTROPIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952596053     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03768.x     Document Type: Article

References (25)

1. Jorgensen, J.O., Pedersen, S.A., Thuesen, L. et al. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1, 1221 1225.
2. Salomon, F., Cuneo, R.C., Hesp, R. et al. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 321, 1797 1803.
3. Bengtsson, B.A., Eden, S., Lonn, L. et al. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 76, 309 317.
4. Binnerts, A., Swart, G.R., Wilson, J.H. et al. (1992) The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 37, 79 87.
5. Whitehead, H.M., Boreham, C., McIlrath, E.M. et al. (1992) Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 36, 45 52.
6. Drake, W.M., Howell, S.J., Monson, J.P. et al. (2001) Optimizing gh therapy in adults and children. Endocrine Reviews 22, 425 450.
7. Drake, W.M., Coyte, D., Camacho-Hubner, C. et al. (1998) Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 83, 3913 3919.
8. Leung, D.W., Spencer, S.A., Cachianes, G. et al. (1987) Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330, 537 543.
9. Godowski, P.J., Leung, D.W., Meacham, L.R. et al. (1989) Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proceedings of the National Academy of Sciences of the United States of America 86, 8083 8087.
10. Pantel, J., Machinis, K., Sobrier, M.L. et al. (2000) Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. Journal of Biological Chemistry 275, 18664 18669.
11. Dos Santos, C., Essioux, L., Teinturier, C. et al. (2004) A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nature Genetics 36, 720 724.
12. Urbanek, M., Russell, J.E., Cooke, N.E. et al. (1993) Functional characterization of the alternatively spliced, placental human growth hormone receptor. Journal of Biological Chemistry 268, 19025 19032.
13. Sobrier, M.L., Duquesnoy, P., Duriez, B. et al. (1993) Expression and binding properties of two isoforms of the human growth hormone receptor. FEBS Letters 319, 16 20.
14. Jorge, A.A., Marchisotti, F.G., Montenegro, L.R. et al. (2006) Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. Journal of Clinical Endocrinology and Metabolism 91, 1076 1080.
15. Carrascosa, A., Audi, L., Esteban, C. et al. (2008) Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH Therapy in Short Small-for- Gestational-Age Children. Journal of Clinical Endocrinology and Metabolism 93, 147 153.
16. Carrascosa, A., Audi, L., Fernandez-Cancio, M. et al. (2008) The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. Journal of Clinical Endocrinology and Metabolism 93, 764 770.
17. Blum, W.F., Machinis, K., Shavrikova, E.P. et al. (2006) The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor. Journal of Clinical Endocrinology and Metabolism 91, 4171 4174.
18. van der Klaauw, A.A., van der Straaten, T., Baak-Pablo, R. et al. (2008) Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 93, 2828 2834.
19. Barbosa, E.J., Palming, J., Glad, C.A. et al. (2008) Influence of the Exon 3-deleted/full-length Growth Hormone Receptor Polymorphism on the Response to Growth Hormone Replacement Therapy in Adults with Severe Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism. 2009 94 (2 639 644. Epub 2008 Dec 2.
20. Schmid, C., Krayenbuehl, P.A., Bernays, R.L. et al. (2007) Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. Clinical Chemistry 53, 1484 1488.
21. Mercado, M., Gonzalez, B., Sandoval, C. et al. (2008) Clinical and Biochemical Impact of the d3 Growth Hormone Receptor Genotype in Acromegaly. Journal of Clinical Endocrinology and Metabolism 93, 3411 3415.
22. Binder, G., Baur, F., Schweizer, R. et al. (2006) The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. Journal of Clinical Endocrinology and Metabolism 91, 659 664.
23. Tauber, M., Ester, W., Auriol, F. et al. (2007) GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism. Clin Endocrinol (Oxf) 67, 457 461.
24. Pilotta, A., Mella, P., Filisetti, M. et al. (2006) Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children. Journal of Clinical Endocrinology and Metabolism 91, 1178 1180.
25. Carrascosa, A., Esteban, C., Espadero, R. et al. (2006) The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients. Journal of Clinical Endocrinology and Metabolism 91, 3281 3286.